Back to Atlas
BSemi-durableStandard research/education caution
CMP-0189
Experimental
DSIP
Sleep / Neuroendocrine
Sleep architecture and stress-resilience positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- Sleep and stress-axis modulation
- Primary market use
- Sleep
Pharmacology
- Molecular weight (Da)
- 849
- Oral bioavailability
- N/A
- Half-life
- 7-8 minutes
- Route tags
- Route-dependent / verify
- Evidence level
- Limited human
- Clinical status
- Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
SQ: • 100 mcg three hours before bedtime (Dr. Seeds, Peptide Therapy) • 250 mcg (some may need up to 450 mcg) at least two hours before bedtime (World of Peptides) • Can be given daily, every 3 days, weekly
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Mostly transient, but sleep normalization may have downstream adaptation